Following partial pancreaticoduodenectomy for periampullary and pancreatic cancer, the complication and mortality rates are particularly high. Various approaches have aimed at improving the postoperative result, with less than complete success. The discouraging results of others, and our own dissatisfaction, led us to evaluate an atraumatic, sutureless method for management of the residual gland. Following head resection, the remaining pancreas is occluded with a fibrin sealant (Tisseel c, Immuno AG, Vienna) via injection into the pancreatic duct, which is then ligated and left free in the peritoneal cavity. Among 44 patients treated with this method, there were no perioperative deaths. Three patients developed local complications (2 fistulae, 1 pancreatitis) due to technical errors that presumably resulted in incomplete occlusion. Evaluation of patients after two to three years indicates that the endocrine function of the pancreas has been largely conserved despite ductal occlusion.
INTRODUCTION
Pancreatic surgery is generally accompanied by a high complication rate and the complication and mortality rates following partial pancreaticoduodenectomy for malignant indication are particularly high [1] [2] [3] [4] [5] [6] [7] [8] [9] (Table 1 ). The average perioperative mortality rate cited for the Whipple procedure has been around 14%, with a range between 3% and 24%, and postoperative complications have been observed in almost half the patients. However, in the past decade morbidity and mortality rates have been falling3'5'6'8'1.
The poor results seen following the Whipple operation are due largely to leakage 3568910 from the pancreaticoenteric anastomosis A variety of surgical techniques have been tried in order to reduce the incidence of pancreatic fistulas resulting from the lytic effects of pancreatic enzymes on the pancreaticoj ejunostomy 4'6'8'9'1 The open pancreatic stump procedure, 11 produced relatively poor results. Its advantage was the absence of perioperative mortality. Splinting (stenting) of the pancreatic duct has also been attempted as a means of protecting the pancreaticoenteric anastomosis from the pancreatic enzymes6'1.
Pancreatic duct ligation, combined with sealing of the surface of the resection area with fibrin sealant also did not produce the desired result and in some patients, reflux resulted in "retention pancreatitis" and subsequent pancreatic tistulae12 '13. Some major centers have abandoned the Whipple procedure in favor of total pancreatectomy because of problems related to pancreaticojejunal dehiscence and the possibility of residual cancer in the stump4'14. In contrast to van 
MATERIAL AND METHOD

Fibrin Sealant
The fibrin sealant (Tisseel c, Immuno AG, Vienna, Austria) has been available for In all patients, we noted a moderate elevation of serum amylase levels postoperatively (400 + 100 IE/1), which subsided after one week. the manifest diabetes can be also attributed to resection of intact pancreatic tissue.
After an observation period of 2 years, 14 of the surviving patients have normal fasting blood sugar levels; 6 of these patients have normal fasting blood sugar after 3 years.
In a control series of 10 patients, pancreatic duct ligation was performed without fibrin sealant occlusion. In this group, 2 patients died of necrotizing pancreatitis, and 2 patients developed pancreatic fistulae. In ten consecutive patients treated at our hospital by partial pancreaticoduodenectomy with pancreaticojejunal anasto- mosis, there were three deaths and four patients had significant perioperative morbidity. Thus, the results obtained with pancreatic duct occlusion using fibrin sealant were clearly superior to those seen either with simple duct ligation, or with pancreaticojejunostomy in our patient population ( Japan, Nakase 4 noted an incidence of dehiscence at the pancreaticojejunostomy site of 14%, while other series report the incidence as being between 11% and 230/05-8. Dehiscence of the pancreaticoenteric anastomosis constitutes the most frequent postoperative complication associated with partial pancreaticoduodenectomy. What is more, it accounts for a high percentage of the perioperative deaths.
Our objective was to minimize postoperative pancreatitis and fistula formation following pancreaticoduodenectomy, by using an atraumatic and fluid-tight procedure, while maintaining endocrine function via conservation of the pancreatic tail. By the use of a low-viscosity fibrin sealant we are able to ensure the complete occlusion of the duct system. The results we have described are very similar to those of Ascherl and co-workers who conducted a comparative study which demonstrated the advantages of fibrin sealing19.
Occlusion of the pancreatic duct with prolamin does not yield uniformly favorable long term results, probably because the high and variable viscosity of this material hampers complete occlusion of the collateral branches19. Furthermore, occlusion with prolamin is usually followed by interstital fibrosis with subsequent high-grade sclerosis of the exocrine pancreatic parenchyma beginning on the second postoperative day, with significant alteration of the endocrine cell function2.
The result is a worthwhile longterm result in endocrine function21. The disadvantage of the fibrin-occlusion without anastomosis is the complete loss of exocrine function and the continous need for treatment with pancreatic enzymes.
In the 44 patients in whom we have used fibrin sealant, we were able to reduce significantly the perioperative mortality as well as the postoperative complication rate of partial pancreaticoduodenectomy by employing fibrin sealant qcclusion of the remaining pancreatic ducts. We continue to see satisfactory long-term results, due to less interstitial reaction and fibrosis with this physiologic substance which doesn't induce a foreign body reaction.
Recently Although the data on endocrine function presented here is limited, it would tend to support the idea that ductal occlusion in humans may have less effect on longterm endocrine function than that reported in the animal model. However, for an accurate assessment of the progressive loss of endocrine function as compared to a sutured anastomosis, a prospective randomized trial would be needed.
The technique presented here should be looked upon as a possible option that requires further assessment. The potential benefits of the fibrin sealant combined
